(Q71105580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

cutaneous lupus erythematosus

16 October 2019

main subject

1 reference

1 reference

J C Prinz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

M Meurer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

C Reiter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

E P Rieber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

G Plewig

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

G Riethmüller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

244-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

FOLLOW UP OF PATIENTS WITH CHRONIC DISCOID LUPUS ERYTHEMATOSUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Induction of tolerance by monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Anti-CD4 mediates clonal anergy during transplantation tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

CD4 engagement induces Fas antigen-dependent apoptosis of T cellsin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Biochemistry of major human histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Beta 2 microglobulin in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Prognostic role of serum beta 2-microglobulin in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Serum beta 2-microglobulin in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Monoclonal anti-CD4 in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980119-8

7 January 2021

10.1016/S0190-9622(96)80119-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8642089%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference